Moderna, Inc.
MRNA
$23.51
-$1.88-7.40%
NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -39.64% | -39.56% | -53.40% | -43.18% | -51.48% |
| Total Other Revenue | -19.46% | 4.20% | -28.25% | -69.53% | -73.10% |
| Total Revenue | -39.05% | -38.35% | -52.75% | -44.29% | -52.60% |
| Cost of Revenue | -35.89% | -33.96% | -37.02% | -37.27% | -7.00% |
| Gross Profit | 30.87% | 27.73% | -3.01% | -15.61% | -276.43% |
| SG&A Expenses | -26.13% | -26.75% | -24.21% | -11.07% | 12.71% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -34.42% | -32.90% | -35.23% | -34.04% | -4.50% |
| Operating Income | 29.39% | 27.44% | 6.94% | -1.05% | -1,003.51% |
| Income Before Tax | 32.02% | 29.07% | 8.50% | 0.17% | -629.58% |
| Income Tax Expenses | -102.74% | -104.20% | -105.96% | -111.63% | 494.60% |
| Earnings from Continuing Operations | 50.52% | 43.75% | 24.46% | 35.83% | -586.08% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 50.52% | 43.75% | 24.46% | 35.83% | -586.08% |
| EBIT | 29.39% | 27.44% | 6.94% | -1.05% | -1,003.51% |
| EBITDA | 25.37% | 22.43% | -3.81% | -9.05% | -568.84% |
| EPS Basic | 51.08% | 44.29% | 25.00% | 36.51% | -601.73% |
| Normalized Basic EPS | 31.77% | 29.98% | 8.80% | 2.04% | -631.06% |
| EPS Diluted | 51.08% | 44.31% | 25.16% | 37.42% | -662.79% |
| Normalized Diluted EPS | 31.79% | 30.00% | 8.55% | 4.67% | -737.43% |
| Average Basic Shares Outstanding | 1.05% | 0.98% | 0.46% | -0.07% | -0.91% |
| Average Diluted Shares Outstanding | 1.04% | 0.97% | -0.77% | -0.76% | -3.81% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |